帕金森病衍生的α-synuclein组合与慢性类型的炎症线索相结合,促进神经毒性微质表现型
Cansu Yildirim-Balatan1,2,3,4, Alexis Fenyi5, Pierre Besnault1,2,3,4
1Sorbonne Université, Paris, France.
Journal of neuroinflammation
|February 21, 2024
概括
帕金森病 (PD) 涉及α-Synuclein (αSYN) 聚合物激活微质细胞. 这项研究揭示了PD衍生的αSYN,TNFα和PGE2创造了一个具有增加谷氨酸和铁保留力的神经毒性微质表型.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 帕金森病 (PD) 与由微质介导的α-Synuclein (αSYN) 聚合和神经炎症有关.
- 通过αSYN激活微质可能驱动PD中的神经退行性过程.
研究的目的:
- 为了研究PD患者衍生的αSYN纤维的炎症潜力.
- 对 PD αSYN 纤维素,TNFα 和 PGE2 (TPFPD) 的组合进行微质反应的特征.
主要方法:
- 主要的微质细胞用αSYN纤维素 (患者衍生和de novo) 和TPFPD.
- 进行了代谢学和转录学分析.
- 微细胞对多巴胺基神经元的毒性活动在体外被评估.
主要成果:
- 来自PD的αSYN纤维素显示出比de novo纤维素更大的炎症强度.
- 与单独αSYN相比,TPFPD诱导了一种独特的微质表型,具有较低的炎症性细胞因子,但较高的谷氨酸释放量.
- 在TPFPD激活的微质中,表现出高调的蛋白质和铁代谢基因,包括Slc7a11,与增加的神经毒性相关.
结论:
- PD衍生的αSYN纤维素,TNFα和PGE2协同诱导一种慢性的神经毒性微质表型.
- 这种表型的特点是谷氨酸释放和铁保留,有助于PD中多巴胺基神经元损伤.
相关概念视频
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K


